Medicaid expansion and cancer stage at diagnoses during the COVID-19 pandemic in the United States
Our findings suggest a protective effect of Medicaid expansion on early-stage cancer diagnoses during the COVID-19 pandemic and public health emergency in the United States, informing policy makers and the public in the 10 states that have yet to expand Medicaid eligibility. Findings can also inform policy makers and the public in all states about the public health implications of upcoming large federal cuts to Medicaid programs and coverage.
Authors
- Ahmedin Jemal (ORCID: https://orcid.org/0000-0002-0000-4111)
- K. Robin Yabroff (ORCID: https://orcid.org/0000-0003-0644-5572)
- Changchuan Jiang (ORCID: https://orcid.org/0000-0002-7392-4154)
- Qinjin Fan (ORCID: https://orcid.org/0000-0002-8409-116X)
- Letícia Nogueira (ORCID: https://orcid.org/0000-0001-6990-3660)
- Xuesong Han (ORCID: https://orcid.org/0000-0001-7159-7949)
- Nuo Yang (ORCID: https://orcid.org/0009-0004-5974-1177)
Institutions
- American Cancer Society (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-08-13
- DOI
- https://doi.org/10.1093/jnci/djaf227
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 1.05